Oblenio Bio
PrivateLast Round
Series B
Jun 25, 2026
Total Funding Raised
$62M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Oblenio Bio is a biotechnology company developing LBL-051, a tri-specific T-cell engager antibody, for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oblenio Bio Comparables
Compare Oblenio Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kali Therapeutics | 86% | |
| Gilead Sciences | 82% | |
| UCB | 81% | |
Oblenio Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 25, 2026 | ||||
| Series A | Nov 7, 2024 |
Key People
Founding team and executive leadership
Oblenio Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aditum Bio | Series B, Series A |
| GV | Series B |
| Deep Track Capital | Series B |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
$62M round led by Pfizer Ventures.
- Nov 7, 2024
Led by Aditum Bio with participation from Nanjing Leads Biolabs.
Oblenio Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oblenio Bio's valuation, stock price, and market status.